Welcome to our dedicated page for Kandal M Venture SEC filings (Ticker: FMFC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Kandal M Venture's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Kandal M Venture's regulatory disclosures and financial reporting.
Kandal M Venture Limited (FMFC) disclosed that the IPO underwriters exercised their full 300,000-share over-allotment option on 9 Jul 2025 and closed the purchase on 16 Jul 2025. The shares, each with a $0.00001 par value, were sold at the IPO price of $4.00, adding roughly $1.2 million of gross proceeds. Inclusive of this greenshoe, the offering generated total gross proceeds of about $9.2 million before underwriting discounts and offering expenses.
The filing is deemed an entry into a material definitive agreement because it finalizes the share purchase terms with Dominari Securities LLC, the representative of the underwriting syndicate. While the added capital strengthens liquidity and signals demand for the stock, it also modestly dilutes existing shareholders; the post-offer share count is not provided.